Translational Psychedelic Research Program, UCSF

Translational Psychedelic Research Program, UCSF The Translational Psychedelic Research Program at UCSF is broadly interested in psychiatry, neurodegenerative disorders, and affective neuroscience.

Director Josh D. Woolley MD/PhD and the Bonding and Attunement in Neuropsychiatric Disorders (BAND) Lab are broadly interested in psychiatry, neurodegenerative disorders, and affective neuroscience. Specifically, Dr. Woolley is interested in the role the neuropeptide oxytocin plays in social functioning and how manipulations of neurohormonal mechanisms involving oxytocin can lead to new therapeutic treatments for a variety of psychiatric conditions. Dr. Woolley studies the effects of oxytocin administration on the negative symptoms of schizophrenia, dyadic family interactions between young adults with mental illness and family members, social funcitoning and preferences for drugs in substance abusers, and team cohesion in ROTC recruits. Our studies evaluate the effects of oxytocin by utilizing behavioral measures as well as neuroimaging methodologies in both clinical and healthy populations. In addition to his work with oxytocin, Dr. Woolley investigates the use of iPad-based cognitive training excercises to treat cognitive deficits in patients with schizophrenia.

Address

401 Parnassus Avenue, Langley Porter Institute
San Francisco, CA
94143

Website

Alerts

Be the first to know and let us send you an email when Translational Psychedelic Research Program, UCSF posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Translational Psychedelic Research Program, UCSF:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category